p53 and FBXW7: Sometimes Two Guardians Are Worse than One
Abstract
:Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Welcker, M.; Orian, A.; Jin, J.; Grim, J.E.; Harper, J.W.; Eisenman, R.B.; Clurman, B.E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. USA 2004, 101, 9085–9090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Koepp, D.M.; Schaefer, L.K.; Ye, X.; Keyomarsi, K.; Chu, C.; Harper, J.W.; Elledge, S.J. Phosphorylation- dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 2001, 294, 173–177. [Google Scholar] [CrossRef] [PubMed]
- Inuzuka, H.; Shaik, S.; Onoyama, I.; Gao, D.; Tseng, A.; Maser, R.S.; Zhai, B.; Wan, L.; Gutierrez, A.; Lau, A.W.; et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011, 471, 104–109. [Google Scholar] [CrossRef] [PubMed]
- Mao, J.H.; Kim, I.J.; Wu, D.; Climent, J.; Kang, H.C.; DelRosario, R.; Balmain, A. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 2008, 321, 1499–1502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wei, W.; Jin, J.; Schlisio, S.; Harper, J.W.; Kaelin, W.G., Jr. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 2005, 8, 25–33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Giráldez, S.; Herrero-Ruiz, J.; Mora-Santos, M.; Japón, M.A.; Tortolero, M.; Romero, F. SCFFBXW7α modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability. Oncotarget 2014, 5, 4370–4383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gupta-Rossi, N.; Le Bail, O.; Gonen, H.; Brou, C.; Logeat, F.; Six, E.; Ciechanover, A.; Israël, A. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 2001, 276, 34371–34378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kwon, Y.W.; Kim, I.J.; Wu, D.; Lu, J.; Stock, W.A., Jr.; Liu, Y.; Huang, Y.; Kang, H.C.; DelRosario, R.; Jen, K.Y.; et al. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation induced tumor development. Mol. Cancer. Res. 2012, 10, 834–844. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Akhoondi, S.; Sun, D.; von der Lehr, N.; Apostolidou, S.; Klotz, K.; Maljukova, A.; Cepeda, D.; Fiegl, H.; Dafou, D.; Marth, C.; et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 2007, 67, 9006–9012. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yeh, C.H.; Bellon, M.; Pancewicz-Wojtkiewicz, J.; Nicot, C. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients. Proc. Natl. Acad. Sci. USA 2016, 113, 6731–6736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Galindo-Moreno, M.; Giráldez, S.; Limón-Mortés, M.C.; Belmonte-Fernández, A.; Reed, S.I.; Sáez, C.; Japón, M.Á.; Tortolero, M.; Romero, F. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage. FASEB J. 2019, 33, 11420–11430. [Google Scholar] [CrossRef] [PubMed]
- Tripathi, V.; Kaur, E.; Kharat, S.S.; Hussain, M.; Damodaran, A.P.; Kulshrestha, S.; Sengupta, S. Abrogation of FBW7α-dependent p53 degradation enhances p53’s function as a tumor suppressor. J. Biol. Chem. 2019, 294, 13224–13232. [Google Scholar] [CrossRef] [PubMed]
- Cui, D.; Xiong, X.; Shu, J.; Dai, X.; Sun, Y.; Zhao, Y. FBXW7 Confers radiation survival by targeting p53 for degradation. Cell Rep. 2020, 30, 497–509. [Google Scholar] [CrossRef] [PubMed]
- Bang, S.; Kaur, S.; Kurokawa, M. Regulation of the p53 family proteins by the ubiquitin proteasomal pathway. Int. J. Mol. Sci. 2019, 21, 261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mao, J.H.; Perez-Losada, J.; Wu, D.; DelRosario, R.; Tsunematsu, R.; Nakayama, K.I.; Brown, K.; Bryson, S.; Balmain, A. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004, 432, 775–779. [Google Scholar] [CrossRef] [PubMed]
- Yokobori, T.; Mimori, K.; Iwatsuki, M.; Ishii, H.; Onoyama, I.; Fukagawa, T.; Kuwano, H.; Nakayama, K.I.; Mori, M. p53-altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res. 2009, 69, 3788–3794. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barak, Y.; Juven, T.; Haffner, R.; Oren, M. Mdm2 expression is induced by wild type p53 activity. EMBO J. 1993, 12, 461–468. [Google Scholar] [CrossRef] [PubMed]
- Leng, R.P.; Lin, Y.; Ma, W.; Wu, H.; Lemmers, B.; Chung, S.; Parant, J.M.; Lozano, G.; Hakem, R.; Benchimol, S. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003, 112, 779–791. [Google Scholar] [CrossRef] [Green Version]
- Dornan, D.; Wertz, I.; Shimizu, H.; Arnott, D.; Frantz, G.D.; Dowd, P.; O’Rourke, K.; Koeppen, H.; Dixit, V.M. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004, 429, 86–92. [Google Scholar] [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Galindo-Moreno, M.; Giráldez, S.; Limón-Mortés, M.C.; Belmonte-Fernández, A.; Sáez, C.; Japón, M.Á.; Tortolero, M.; Romero, F. p53 and FBXW7: Sometimes Two Guardians Are Worse than One. Cancers 2020, 12, 985. https://doi.org/10.3390/cancers12040985
Galindo-Moreno M, Giráldez S, Limón-Mortés MC, Belmonte-Fernández A, Sáez C, Japón MÁ, Tortolero M, Romero F. p53 and FBXW7: Sometimes Two Guardians Are Worse than One. Cancers. 2020; 12(4):985. https://doi.org/10.3390/cancers12040985
Chicago/Turabian StyleGalindo-Moreno, María, Servando Giráldez, M. Cristina Limón-Mortés, Alejandro Belmonte-Fernández, Carmen Sáez, Miguel Á. Japón, Maria Tortolero, and Francisco Romero. 2020. "p53 and FBXW7: Sometimes Two Guardians Are Worse than One" Cancers 12, no. 4: 985. https://doi.org/10.3390/cancers12040985